<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p14" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_14{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_14{left:341px;bottom:30px;}
#t3_14{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_14{left:377px;bottom:30px;}
#t5_14{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_14{left:540px;bottom:30px;}
#t7_14{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_14{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_14{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_14{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_14{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_14{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_14{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_14{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_14{left:1130px;bottom:47px;letter-spacing:0.27px;}
#tg_14{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_14{left:438px;bottom:777px;letter-spacing:0.39px;word-spacing:-0.22px;}
#ti_14{left:765px;bottom:784px;}
#tj_14{left:36px;bottom:282px;}
#tk_14{left:46px;bottom:276px;letter-spacing:0.08px;word-spacing:-0.01px;}
#tl_14{left:377px;bottom:276px;letter-spacing:0.12px;}
#tm_14{left:407px;bottom:276px;letter-spacing:0.13px;}
#tn_14{left:481px;bottom:276px;}
#to_14{left:36px;bottom:266px;}
#tp_14{left:46px;bottom:260px;letter-spacing:0.12px;word-spacing:0.01px;}
#tq_14{left:36px;bottom:249px;}
#tr_14{left:46px;bottom:243px;letter-spacing:0.12px;word-spacing:-0.03px;}
#ts_14{left:557px;bottom:243px;}
#tt_14{left:36px;bottom:232px;}
#tu_14{left:46px;bottom:226px;letter-spacing:0.11px;}
#tv_14{left:116px;bottom:226px;letter-spacing:0.12px;word-spacing:0.01px;}
#tw_14{left:1081px;bottom:226px;}
#tx_14{left:45px;bottom:209px;letter-spacing:0.14px;}
#ty_14{left:36px;bottom:198px;}
#tz_14{left:46px;bottom:192px;letter-spacing:0.11px;word-spacing:-0.04px;}
#t10_14{left:45px;bottom:176px;letter-spacing:0.13px;}
#t11_14{left:36px;bottom:165px;}
#t12_14{left:46px;bottom:159px;letter-spacing:0.1px;word-spacing:-0.03px;}
#t13_14{left:45px;bottom:142px;letter-spacing:0.12px;word-spacing:0.01px;}
#t14_14{left:36px;bottom:131px;letter-spacing:0.08px;}
#t15_14{left:53px;bottom:125px;letter-spacing:0.1px;}
#t16_14{left:45px;bottom:108px;letter-spacing:0.12px;word-spacing:0.01px;}
#t17_14{left:36px;bottom:748px;letter-spacing:-0.24px;}
#t18_14{left:36px;bottom:729px;letter-spacing:-0.1px;}
#t19_14{left:351px;bottom:737px;letter-spacing:-0.13px;}
#t1a_14{left:36px;bottom:711px;}
#t1b_14{left:47px;bottom:711px;letter-spacing:-0.09px;}
#t1c_14{left:36px;bottom:693px;letter-spacing:-0.1px;}
#t1d_14{left:41px;bottom:674px;}
#t1e_14{left:58px;bottom:674px;letter-spacing:-0.09px;word-spacing:-0.05px;}
#t1f_14{left:731px;bottom:674px;letter-spacing:-0.12px;}
#t1g_14{left:771px;bottom:674px;}
#t1h_14{left:63px;bottom:656px;}
#t1i_14{left:76px;bottom:656px;letter-spacing:-0.09px;}
#t1j_14{left:41px;bottom:638px;}
#t1k_14{left:58px;bottom:638px;letter-spacing:-0.09px;}
#t1l_14{left:63px;bottom:619px;}
#t1m_14{left:76px;bottom:619px;letter-spacing:-0.09px;}
#t1n_14{left:547px;bottom:627px;}
#t1o_14{left:36px;bottom:564px;letter-spacing:-0.09px;}
#t1p_14{left:134px;bottom:564px;letter-spacing:-0.08px;}
#t1q_14{left:224px;bottom:564px;letter-spacing:-0.1px;}
#t1r_14{left:36px;bottom:528px;letter-spacing:-0.09px;}
#t1s_14{left:36px;bottom:509px;}
#t1t_14{left:47px;bottom:509px;letter-spacing:-0.1px;}
#t1u_14{left:36px;bottom:491px;}
#t1v_14{left:47px;bottom:491px;letter-spacing:-0.1px;}
#t1w_14{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_14{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_14{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_14{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_14{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_14{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_14{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_14{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s7_14{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s8_14{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s9_14{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sa_14{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sb_14{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_14{font-size:17px;font-family:Webdings_k6;color:#000;}
.sd_14{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.se_14{font-size:17px;font-family:SymbolMT_ka;color:#000;}
.sf_14{font-size:17px;font-family:Arial-BoldMT_jz;color:#0065A4;}
.sg_14{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts14" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

@font-face {
	font-family: SymbolMT_ka;
	src: url("fonts/SymbolMT_ka.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg14Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg14" style="-webkit-user-select: none;"><object width="1210" height="935" data="14/14.svg" type="image/svg+xml" id="pdf14" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_14" class="t s0_14">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_14" class="t s1_14">® </span>
<span id="t3_14" class="t s0_14">(NCCN </span>
<span id="t4_14" class="t s1_14">® </span>
<span id="t5_14" class="t s0_14">), All rights reserved. NCCN Guidelines </span>
<span id="t6_14" class="t s1_14">® </span>
<span id="t7_14" class="t s0_14">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_14" class="t s2_14">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_14" class="t s2_14">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_14" class="t s3_14">NCCN Guidelines Version 4.2024 </span>
<span id="tb_14" class="t s3_14">Cancer of the Oral Cavity (Including Mucosal Lip) </span>
<span id="tc_14" class="t s4_14">NCCN Guidelines Index </span>
<span id="td_14" class="t s4_14">Table of Contents </span>
<span id="te_14" class="t s4_14">Discussion </span>
<span id="tf_14" class="t s5_14">OR-A </span>
<span id="tg_14" class="t s5_14">2 OF 2 </span>
<span id="th_14" class="t s5_14">PRINCIPLES OF RADIATION THERAPY </span>
<span id="ti_14" class="t s6_14">1 </span>
<span id="tj_14" class="t s7_14">1 </span>
<span id="tk_14" class="t s8_14">See Principles of Radiation Techniques (RAD-A) </span><span id="tl_14" class="t s9_14">and </span><span id="tm_14" class="t s8_14">Discussion</span><span id="tn_14" class="t s9_14">. </span>
<span id="to_14" class="t s7_14">3 </span>
<span id="tp_14" class="t s9_14">Suggest 44–50 Gy in 3D-CRT and sequentially planned IMRT or 54–63 Gy with IMRT dose painting technique (dependent on dose per fraction). </span>
<span id="tq_14" class="t s7_14">6 </span>
<span id="tr_14" class="t s8_14">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="ts_14" class="t s9_14">. </span>
<span id="tt_14" class="t s7_14">7 </span>
<span id="tu_14" class="t s9_14">Bernier J, </span><span id="tv_14" class="t sa_14">Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. </span><span id="tw_14" class="t s9_14">N </span>
<span id="tx_14" class="t s9_14">Engl J Med 2004;350:1945-1952. </span>
<span id="ty_14" class="t s7_14">8 </span>
<span id="tz_14" class="t s9_14">Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and </span>
<span id="t10_14" class="t s9_14">neck. N Engl J Med 2004;350:1937-1944. </span>
<span id="t11_14" class="t s7_14">9 </span>
<span id="t12_14" class="t s9_14">Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative </span>
<span id="t13_14" class="t s9_14">radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27:843-850. </span>
<span id="t14_14" class="t s7_14">10 </span>
<span id="t15_14" class="t s9_14">Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and </span>
<span id="t16_14" class="t s9_14">chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;84:1198-1205. </span>
<span id="t17_14" class="t s5_14">POSTOPERATIVE: </span>
<span id="t18_14" class="t s5_14">RT or Concurrent Systemic Therapy/RT </span>
<span id="t19_14" class="t s6_14">6-10 </span>
<span id="t1a_14" class="t s5_14">• </span><span id="t1b_14" class="t sb_14">Preferred interval between resection and postoperative RT is ≤6 weeks. </span>
<span id="t1c_14" class="t s5_14">• PTV </span>
<span id="t1d_14" class="t sc_14"></span><span id="t1e_14" class="t s5_14">High risk: Adverse pathologic features such as positive margins (see footnote m on </span><span id="t1f_14" class="t sd_14">OR-3</span><span id="t1g_14" class="t s5_14">) </span>
<span id="t1h_14" class="t se_14">◊ </span><span id="t1i_14" class="t s5_14">60–66 Gy (2.0 Gy/fraction); daily Monday–Friday in 6–6.5 weeks </span>
<span id="t1j_14" class="t sc_14"></span><span id="t1k_14" class="t s5_14">Low to intermediate risk: Sites of suspected subclinical spread </span>
<span id="t1l_14" class="t se_14">◊ </span><span id="t1m_14" class="t s5_14">44–50 Gy (2.0 Gy/fraction) to 54–63 Gy (1.6–1.8 Gy/fraction) </span>
<span id="t1n_14" class="t s6_14">3 </span>
<span id="t1o_14" class="t s5_14">Either IMRT </span><span id="t1p_14" class="t s5_14">(preferred) </span><span id="t1q_14" class="t s5_14">or 3D-CRT is recommended. </span>
<span id="t1r_14" class="t s5_14">For T1–T2 simple lip lesions, treat with postoperative RT as per non-melanoma skin cancers. </span>
<span id="t1s_14" class="t s5_14">• </span><span id="t1t_14" class="t sd_14">NCCN Guidelines for Basal Cell Skin Cancer </span>
<span id="t1u_14" class="t s5_14">• </span><span id="t1v_14" class="t sf_14">NCCN Guidelines for Squamous Cell Skin Cancer </span>
<span id="t1w_14" class="t sg_14">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
